49 results on '"Sahara, Makoto"'
Search Results
2. Epicardioid single-cell genomics uncovers principles of human epicardium biology in heart development and disease.
- Author
-
Meier AB, Zawada D, De Angelis MT, Martens LD, Santamaria G, Zengerle S, Nowak-Imialek M, Kornherr J, Zhang F, Tian Q, Wolf CM, Kupatt C, Sahara M, Lipp P, Theis FJ, Gagneur J, Goedel A, Laugwitz KL, Dorn T, and Moretti A
- Subjects
- Humans, Myocardium, Cell Differentiation genetics, Cell Lineage genetics, Biology, Pericardium metabolism, Heart
- Abstract
The epicardium, the mesothelial envelope of the vertebrate heart, is the source of multiple cardiac cell lineages during embryonic development and provides signals that are essential to myocardial growth and repair. Here we generate self-organizing human pluripotent stem cell-derived epicardioids that display retinoic acid-dependent morphological, molecular and functional patterning of the epicardium and myocardium typical of the left ventricular wall. By combining lineage tracing, single-cell transcriptomics and chromatin accessibility profiling, we describe the specification and differentiation process of different cell lineages in epicardioids and draw comparisons to human fetal development at the transcriptional and morphological levels. We then use epicardioids to investigate the functional cross-talk between cardiac cell types, gaining new insights into the role of IGF2/IGF1R and NRP2 signaling in human cardiogenesis. Finally, we show that epicardioids mimic the multicellular pathogenesis of congenital or stress-induced hypertrophy and fibrotic remodeling. As such, epicardioids offer a unique testing ground of epicardial activity in heart development, disease and regeneration., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
3. Placental growth factor exerts a dual function for cardiomyogenesis and vasculogenesis during heart development.
- Author
-
Witman N, Zhou C, Häneke T, Xiao Y, Huang X, Rohner E, Sohlmér J, Grote Beverborg N, Lehtinen ML, Chien KR, and Sahara M
- Subjects
- Female, Humans, Animals, Mice, Placenta Growth Factor, Myocytes, Cardiac, Cell Differentiation, Endothelial Cells, Myocardium
- Abstract
Cardiogenic growth factors play important roles in heart development. Placental growth factor (PLGF) has previously been reported to have angiogenic effects; however, its potential role in cardiogenesis has not yet been determined. We analyze single-cell RNA-sequencing data derived from human and primate embryonic hearts and find PLGF shows a biphasic expression pattern, as it is expressed specifically on ISL1
+ second heart field progenitors at an earlier stage and on vascular smooth muscle cells (SMCs) and endothelial cells (ECs) at later stages. Using chemically modified mRNAs (modRNAs), we generate a panel of cardiogenic growth factors and test their effects on enhancing cardiomyocyte (CM) and EC induction during different stages of human embryonic stem cell (hESC) differentiations. We discover that only the application of PLGF modRNA at early time points of hESC-CM differentiation can increase both CM and EC production. Conversely, genetic deletion of PLGF reduces generation of CMs, SMCs and ECs in vitro. We also confirm in vivo beneficial effects of PLGF modRNA for development of human heart progenitor-derived cardiac muscle grafts on murine kidney capsules. Further, we identify the previously unrecognized PLGF-related transcriptional networks driven by EOMES and SOX17. These results shed light on the dual cardiomyogenic and vasculogenic effects of PLGF during heart development., (© 2023. Springer Nature Limited.)- Published
- 2023
- Full Text
- View/download PDF
4. STRA6 is essential for induction of vascular smooth muscle lineages in human embryonic cardiac outflow tract development.
- Author
-
Zhou C, Häneke T, Rohner E, Sohlmér J, Kameneva P, Artemov A, Adameyko I, and Sahara M
- Subjects
- Humans, Animals, Mice, Heart, Gene Expression Regulation, Tretinoin pharmacology, Tretinoin metabolism, Vitamin A, Membrane Proteins genetics, Membrane Proteins metabolism, Muscle, Smooth, Vascular metabolism, Heart Defects, Congenital genetics
- Abstract
Aims: Retinoic acid (RA) signalling is essential for heart development, and dysregulation of the RA signalling can cause several types of cardiac outflow tract (OFT) defects, the most frequent congenital heart disease (CHD) in humans. Matthew-Wood syndrome is caused by inactivating mutations of a transmembrane protein gene STRA6 that transports vitamin A (retinol) from extracellular into intracellular spaces. This syndrome shows a broad spectrum of malformations including CHD, although murine Stra6-null neonates did not exhibit overt heart defects. Thus, the detailed mechanisms by which STRA6 mutations could lead to cardiac malformations in humans remain unclear. Here, we investigated the role of STRA6 in the context of human cardiogenesis and CHD., Methods and Results: To gain molecular signatures in species-specific cardiac development, we first compared single-cell RNA sequencing (RNA-seq) datasets, uniquely obtained from human and murine embryonic hearts. We found that while STRA6 mRNA was much less frequently expressed in murine embryonic heart cells derived from the Mesp1+ lineage tracing mice (Mesp1Cre/+; Rosa26tdTomato), it was expressed predominantly in the OFT region-specific heart progenitors in human developing hearts. Next, we revealed that STRA6-knockout human embryonic stem cells (hESCs) could differentiate into cardiomyocytes similarly to wild-type hESCs, but could not differentiate properly into mesodermal nor neural crest cell-derived smooth muscle cells (SMCs) in vitro. This is supported by the population RNA-seq data showing down-regulation of the SMC-related genes in the STRA6-knockout hESC-derived cells. Further, through machinery assays, we identified the previously unrecognized interaction between RA nuclear receptors RARα/RXRα and TBX1, an OFT-specific cardiogenic transcription factor, which would likely act downstream to STRA6-mediated RA signalling in human cardiogenesis., Conclusion: Our study highlights the critical role of human-specific STRA6 progenitors for proper induction of vascular SMCs that is essential for normal OFT formation. Thus, these results shed light on novel and human-specific CHD mechanisms, driven by STRA6 mutations., Competing Interests: Conflict of interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.)
- Published
- 2023
- Full Text
- View/download PDF
5. Recent Advances in Generation of In Vitro Cardiac Organoids.
- Author
-
Sahara M
- Subjects
- Organoids, Regenerative Medicine methods, Fibroblasts, Endothelial Cells, Pluripotent Stem Cells
- Abstract
Cardiac organoids are in vitro self-organizing and three-dimensional structures composed of multiple cardiac cells (i.e., cardiomyocytes, endothelial cells, cardiac fibroblasts, etc.) with or without biological scaffolds. Since cardiac organoids recapitulate structural and functional characteristics of the native heart to a higher degree compared to the conventional two-dimensional culture systems, their applications, in combination with pluripotent stem cell technologies, are being widely expanded for the investigation of cardiogenesis, cardiac disease modeling, drug screening and development, and regenerative medicine. In this mini-review, recent advances in cardiac organoid technologies are summarized in chronological order, with a focus on the methodological points for each organoid formation. Further, the current limitations and the future perspectives in these promising systems are also discussed.
- Published
- 2023
- Full Text
- View/download PDF
6. Progress in Bioengineering Strategies for Heart Regenerative Medicine.
- Author
-
Häneke T and Sahara M
- Subjects
- Bioengineering, Humans, Myocytes, Cardiac, Regenerative Medicine, Tissue Engineering, Heart Diseases therapy, Pluripotent Stem Cells
- Abstract
The human heart has the least regenerative capabilities among tissues and organs, and heart disease continues to be a leading cause of mortality in the industrialized world with insufficient therapeutic options and poor prognosis. Therefore, developing new therapeutic strategies for heart regeneration is a major goal in modern cardiac biology and medicine. Recent advances in stem cell biology and biotechnologies such as human pluripotent stem cells (hPSCs) and cardiac tissue engineering hold great promise for opening novel paths to heart regeneration and repair for heart disease, although these areas are still in their infancy. In this review, we summarize and discuss the recent progress in cardiac tissue engineering strategies, highlighting stem cell engineering and cardiomyocyte maturation, development of novel functional biomaterials and biofabrication tools, and their therapeutic applications involving drug discovery, disease modeling, and regenerative medicine for heart disease.
- Published
- 2022
- Full Text
- View/download PDF
7. Uncovering the molecular identity of cardiosphere-derived cells (CDCs) by single-cell RNA sequencing.
- Author
-
Kogan PS, Wirth F, Tomar A, Darr J, Teperino R, Lahm H, Dreßen M, Puluca N, Zhang Z, Neb I, Beck N, Luzius T, de la Osa de la Rosa L, Gärtner K, Hüls C, Zeidler R, Ramanujam D, Engelhardt S, Wenk C, Holdt LM, Mononen M, Sahara M, Cleuziou J, Hörer J, Lange R, Krane M, and Doppler SA
- Subjects
- Adult, Humans, Myocytes, Cardiac, Sequence Analysis, RNA, Stem Cells, Endothelial Cells
- Abstract
Cardiosphere-derived cells (CDCs) generated from human cardiac biopsies have been shown to have disease-modifying bioactivity in clinical trials. Paradoxically, CDCs' cellular origin in the heart remains elusive. We studied the molecular identity of CDCs using single-cell RNA sequencing (sc-RNAseq) in comparison to cardiac non-myocyte and non-hematopoietic cells (cardiac fibroblasts/CFs, smooth muscle cells/SMCs and endothelial cells/ECs). We identified CDCs as a distinct and mitochondria-rich cell type that shared biological similarities with non-myocyte cells but not with cardiac progenitor cells derived from human-induced pluripotent stem cells. CXCL6 emerged as a new specific marker for CDCs. By analysis of sc-RNAseq data from human right atrial biopsies in comparison with CDCs we uncovered transcriptomic similarities between CDCs and CFs. By direct comparison of infant and adult CDC sc-RNAseq data, infant CDCs revealed GO-terms associated with cardiac development. To analyze the beneficial effects of CDCs (pro-angiogenic, anti-fibrotic, anti-apoptotic), we performed functional in vitro assays with CDC-derived extracellular vesicles (EVs). CDC EVs augmented in vitro angiogenesis and did not stimulate scarring. They also reduced the expression of pro-apoptotic Bax in NRCMs. In conclusion, CDCs were disclosed as mitochondria-rich cells with unique properties but also with similarities to right atrial CFs. CDCs displayed highly proliferative, secretory and immunomodulatory properties, characteristics that can also be found in activated or inflammatory cell types. By special culture conditions, CDCs earn some bioactivities, including angiogenic potential, which might modify disease in certain disorders., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
8. Sequencing of a Chinese tetralogy of Fallot cohort reveals clustering mutations in myogenic heart progenitors.
- Author
-
Tang CSM, Mononen M, Lam WY, Jin SC, Zhuang X, Garcia-Barcelo MM, Lin Q, Yang Y, Sahara M, Eroglu E, Chien KR, Hong H, Tam PKH, and Gruber PJ
- Subjects
- Asian People genetics, China epidemiology, Cluster Analysis, Gene Regulatory Networks genetics, Genetic Association Studies methods, Genetic Variation, Humans, Myocytes, Cardiac physiology, Polymorphism, Single Nucleotide, Whole Genome Sequencing methods, Embryonic Induction genetics, Heart embryology, Tetralogy of Fallot ethnology, Tetralogy of Fallot genetics
- Abstract
Tetralogy of Fallot (TOF) is the most common cyanotic heart defect, yet the underlying genetic mechanisms remain poorly understood. Here, we performed whole-genome sequencing analysis on 146 nonsyndromic TOF parent-offspring trios of Chinese ethnicity. Comparison of de novo variants and recessive genotypes of this data set with data from a European cohort identified both overlapping and potentially novel gene loci and revealed differential functional enrichment between cohorts. To assess the impact of these mutations on early cardiac development, we integrated single-cell and spatial transcriptomics of early human heart development with our genetic findings. We discovered that the candidate gene expression was enriched in the myogenic progenitors of the cardiac outflow tract. Moreover, subsets of the candidate genes were found in specific gene coexpression modules along the cardiomyocyte differentiation trajectory. These integrative functional analyses help dissect the pathogenesis of TOF, revealing cellular hotspots in early heart development resulting in cardiac malformations.
- Published
- 2022
- Full Text
- View/download PDF
9. Sequential Defects in Cardiac Lineage Commitment and Maturation Cause Hypoplastic Left Heart Syndrome.
- Author
-
Krane M, Dreßen M, Santamaria G, My I, Schneider CM, Dorn T, Laue S, Mastantuono E, Berutti R, Rawat H, Gilsbach R, Schneider P, Lahm H, Schwarz S, Doppler SA, Paige S, Puluca N, Doll S, Neb I, Brade T, Zhang Z, Abou-Ajram C, Northoff B, Holdt LM, Sudhop S, Sahara M, Goedel A, Dendorfer A, Tjong FVY, Rijlaarsdam ME, Cleuziou J, Lang N, Kupatt C, Bezzina C, Lange R, Bowles NE, Mann M, Gelb BD, Crotti L, Hein L, Meitinger T, Wu S, Sinnecker D, Gruber PJ, Laugwitz KL, and Moretti A
- Subjects
- Genetic Heterogeneity, Humans, Hypoplastic Left Heart Syndrome genetics, Organogenesis genetics
- Abstract
Background: Complex molecular programs in specific cell lineages govern human heart development. Hypoplastic left heart syndrome (HLHS) is the most common and severe manifestation within the spectrum of left ventricular outflow tract obstruction defects occurring in association with ventricular hypoplasia. The pathogenesis of HLHS is unknown, but hemodynamic disturbances are assumed to play a prominent role., Methods: To identify perturbations in gene programs controlling ventricular muscle lineage development in HLHS, we performed whole-exome sequencing of 87 HLHS parent-offspring trios, nuclear transcriptomics of cardiomyocytes from ventricles of 4 patients with HLHS and 15 controls at different stages of heart development, single cell RNA sequencing, and 3D modeling in induced pluripotent stem cells from 3 patients with HLHS and 3 controls., Results: Gene set enrichment and protein network analyses of damaging de novo mutations and dysregulated genes from ventricles of patients with HLHS suggested alterations in specific gene programs and cellular processes critical during fetal ventricular cardiogenesis, including cell cycle and cardiomyocyte maturation. Single-cell and 3D modeling with induced pluripotent stem cells demonstrated intrinsic defects in the cell cycle/unfolded protein response/autophagy hub resulting in disrupted differentiation of early cardiac progenitor lineages leading to defective cardiomyocyte subtype differentiation/maturation in HLHS. Premature cell cycle exit of ventricular cardiomyocytes from patients with HLHS prevented normal tissue responses to developmental signals for growth, leading to multinucleation/polyploidy, accumulation of DNA damage, and exacerbated apoptosis, all potential drivers of left ventricular hypoplasia in absence of hemodynamic cues., Conclusions: Our results highlight that despite genetic heterogeneity in HLHS, many mutations converge on sequential cellular processes primarily driving cardiac myogenesis, suggesting novel therapeutic approaches.
- Published
- 2021
- Full Text
- View/download PDF
10. An mRNA assay system demonstrates proteasomal-specific degradation contributes to cardiomyopathic phospholamban null mutation.
- Author
-
Rohner E, Witman N, Sohlmer J, De Genst E, Louch WE, Sahara M, and Chien KR
- Subjects
- Alleles, Amino Acid Substitution, Biomarkers, Calcium-Binding Proteins chemistry, Calcium-Binding Proteins metabolism, Cardiomyopathies diagnosis, Cell Line, Disease Susceptibility, Gene Expression Profiling, Humans, Protein Biosynthesis, RNA Stability, Calcium-Binding Proteins genetics, Cardiomyopathies etiology, Cardiomyopathies metabolism, Homozygote, Mutation, Proteasome Endopeptidase Complex metabolism, RNA, Messenger genetics
- Abstract
Background: The human L39X phospholamban (PLN) cardiomyopathic mutant has previously been reported as a null mutation but the detailed molecular pathways that lead to the complete lack of detectable protein remain to be clarified. Previous studies have shown the implication between an impaired cellular degradation homeostasis and cardiomyopathy development. Therefore, uncovering the underlying mechanism responsible for the lack of PLN protein has important implications in understanding the patient pathology, chronic human calcium dysregulation and aid the development of potential therapeutics., Methods: A panel of mutant and wild-type reporter tagged PLN modified mRNA (modRNA) constructs were transfected in human embryonic stem cell-derived cardiomyocytes. Lysosomal and proteasomal chemical inhibitors were used together with cell imaging and protein analysis tools in order to dissect degradation pathways associated with expressed PLN constructs. Transcriptional profiling of the cardiomyocytes transfected by wild-type or L39X mutant PLN modRNA was analysed with bulk RNA sequencing., Results: Our modRNA assay system revealed that transfected L39X mRNA was stable and actively translated in vitro but with only trace amount of protein detectable. Proteasomal inhibition of cardiomyocytes transfected with L39X mutant PLN modRNA showed a fourfold increase in protein expression levels. Additionally, RNA sequencing analysis of protein degradational pathways showed a significant distinct transcriptomic signature between wild-type and L39X mutant PLN modRNA transfected cardiomyocytes., Conclusion: Our results demonstrate that the cardiomyopathic PLN null mutant L39X is rapidly, actively and specifically degraded by proteasomal pathways. Herein, and to the best of our knowledge, we report for the first time the usage of modified mRNAs to screen for and illuminate alternative molecular pathways found in genes associated with inherited cardiomyopathies., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
11. Isolation of human ESC-derived cardiac derivatives and embryonic heart cells for population and single-cell RNA-seq analysis.
- Author
-
Santoro F, Chien KR, and Sahara M
- Subjects
- Embryo, Mammalian cytology, Embryo, Mammalian metabolism, Humans, Cell Differentiation, Flow Cytometry, Human Embryonic Stem Cells cytology, Human Embryonic Stem Cells metabolism, Myocardium cytology, Myocardium metabolism, RNA-Seq, Single-Cell Analysis
- Abstract
The combination of population and single-cell RNA sequencing analysis using human embryonic stem cell (hESC) differentiation and developmental tissues is a powerful approach to elucidate an organ-specific cellular and molecular atlas in human embryogenesis. This protocol describes (1) cardiac-directed differentiation and isolation of hESC-derived cardiac derivatives with fluorescence-activated cell sorting, (2) isolation of human embryonic heart-derived single cardiac cells, and (3) construction of cDNA libraries with Smart-seq2. These allow for the preparation of human developmental samples for comprehensive transcriptional analysis. For complete details on the use and execution of this protocol, please refer to Sahara et al. (2019)., Competing Interests: The authors declare no competing interests., (© 2021 The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
12. Corrigendum to "Cardiac progenitors and paracrine mediators in cardiogenesis and heart regeneration" [Semin. Cell Dev. Biol. Vol.100 (2020) 29-51].
- Author
-
Witman N, Zhou C, Beverborg NG, Sahara M, and Chien KR
- Published
- 2021
- Full Text
- View/download PDF
13. Genome-wide CRISPR screen identifies ZIC2 as an essential gene that controls the cell fate of early mesodermal precursors to human heart progenitors.
- Author
-
Xu J, Zhou C, Foo KS, Yang R, Xiao Y, Bylund K, Sahara M, and Chien KR
- Subjects
- Animals, Cell Differentiation, Disease Models, Animal, Humans, Mice, Clustered Regularly Interspaced Short Palindromic Repeats genetics, Genome-Wide Association Study methods, Heart physiopathology, Mesoderm metabolism, Nuclear Proteins metabolism, Transcription Factors metabolism
- Abstract
Cardiac progenitor formation is one of the earliest committed steps of human cardiogenesis and requires the cooperation of multiple gene sets governed by developmental signaling cascades. To determine the key regulators for cardiac progenitor formation, we have developed a two-stage genome-wide CRISPR-knockout screen. We mimicked the progenitor formation process by differentiating human pluripotent stem cells (hPSCs) into cardiomyocytes, monitored by two distinct stage markers of early cardiac mesodermal formation and commitment to a multipotent heart progenitor cell fate: MESP1 and ISL1, respectively. From the screen output, we compiled a list of 15 candidate genes. After validating seven of them, we identified ZIC2 as an essential gene for cardiac progenitor formation. ZIC2 is known as a master regulator of neurogenesis. hPSCs with ZIC2 mutated still express pluripotency markers. However, their ability to differentiate into cardiomyocytes was greatly attenuated. RNA-Seq profiling of the ZIC2-mutant cells revealed that the mutants switched their cell fate alternatively to the noncardiac cell lineage. Further, single cell RNA-seq analysis showed the ZIC2 mutants affected the apelin receptor-related signaling pathway during mesoderm formation. Our results provide a new link between ZIC2 and human cardiogenesis and document the potential power of a genome-wide unbiased CRISPR-knockout screen to identify the key steps in human mesoderm precursor cell- and heart progenitor cell-fate determination during in vitro hPSC cardiogenesis., (©AlphaMed Press 2020.)
- Published
- 2020
- Full Text
- View/download PDF
14. Cardiac progenitors and paracrine mediators in cardiogenesis and heart regeneration.
- Author
-
Witman N, Zhou C, Grote Beverborg N, Sahara M, and Chien KR
- Subjects
- Animals, Humans, Myocardium cytology, Myocytes, Cardiac cytology, Pluripotent Stem Cells cytology, Tissue Engineering, Myocardium metabolism, Myocytes, Cardiac metabolism, Paracrine Communication, Pluripotent Stem Cells metabolism, Regeneration
- Abstract
The mammalian hearts have the least regenerative capabilities among tissues and organs. As such, heart regeneration has been and continues to be the ultimate goal in the treatment against acquired and congenital heart diseases. Uncovering such a long-awaited therapy is still extremely challenging in the current settings. On the other hand, this desperate need for effective heart regeneration has developed various forms of modern biotechnologies in recent years. These involve the transplantation of pluripotent stem cell-derived cardiac progenitors or cardiomyocytes generated in vitro and novel biochemical molecules along with tissue engineering platforms. Such newly generated technologies and approaches have been shown to effectively proliferate cardiomyocytes and promote heart repair in the diseased settings, albeit mainly preclinically. These novel tools and medicines give somehow credence to breaking down the barriers associated with re-building heart muscle. However, in order to maximize efficacy and achieve better clinical outcomes through these cell-based and/or cell-free therapies, it is crucial to understand more deeply the developmental cellular hierarchies/paths and molecular mechanisms in normal or pathological cardiogenesis. Indeed, the morphogenetic process of mammalian cardiac development is highly complex and spatiotemporally regulated by various types of cardiac progenitors and their paracrine mediators. Here we discuss the most recent knowledge and findings in cardiac progenitor cell biology and the major cardiogenic paracrine mediators in the settings of cardiogenesis, congenital heart disease, and heart regeneration., Competing Interests: Declaration of Competing Interest The authors declare no conflict of interest., (Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
15. In search of the next super models.
- Author
-
Goedel A, Grote Beverborg N, Sahara M, and Chien KR
- Subjects
- Actinin, Drug Discovery, Humans, Mutation, Cardiomyopathy, Hypertrophic, Pluripotent Stem Cells
- Abstract
The advent of pluripotent stem cell biology and facile genetic manipulation via CRISPR technology has ushered in a new era of human disease models for drug discovery and development. While these precision "super models" hold great promise for tailoring personalized therapy, their full potential and in vivo validation have remained elusive., (© 2019 The Authors. Published under the terms of the CC BY 4.0 license.)
- Published
- 2019
- Full Text
- View/download PDF
16. Cell-mediated delivery of VEGF modified mRNA enhances blood vessel regeneration and ameliorates murine critical limb ischemia.
- Author
-
Yu Z, Witman N, Wang W, Li D, Yan B, Deng M, Wang X, Wang H, Zhou G, Liu W, Sahara M, Cao Y, Fritsche-Danielson R, Zhang W, Fu W, and Chien KR
- Subjects
- Animals, Capillaries metabolism, Capillaries physiopathology, Disease Models, Animal, Femoral Artery metabolism, Femoral Artery pathology, Femoral Artery physiopathology, Hindlimb blood supply, Hindlimb pathology, Hindlimb physiopathology, Humans, Ischemia pathology, Ischemia physiopathology, Microcirculation physiology, RNA, Messenger administration & dosage, Regeneration, Transfection, Vascular Endothelial Growth Factor A administration & dosage, Fibroblasts metabolism, Gene Transfer Techniques, Ischemia therapy, Neovascularization, Physiologic physiology, RNA, Messenger genetics, Vascular Endothelial Growth Factor A genetics
- Abstract
Synthetic chemically modified mRNAs (modRNA) encoding vascular endothelial growth factor (VEGF) represents an alternative to gene therapy for the treatment of ischemic cardiovascular injuries. However, novel delivery approaches of modRNA are needed to improve therapeutic efficacy in the diseased setting. We hypothesized that cell-mediated modRNA delivery may enhance the in vivo expression kinetics of VEGF protein thus promoting more potent angiogenic effects. Here, we employed skin fibroblasts as a "proof of concept" to probe the therapeutic potential of a cell-mediated mRNA delivery system in a murine model of critical limb ischemia (CLI). We show that fibroblasts pre-treated with VEGF modRNA have the potential to fully salvage ischemic limbs. Using detailed molecular analysis we reveal that a fibroblast-VEGF modRNA combinatorial treatment significantly reduced tissue necrosis and dramatically improved vascular densities in CLI-injured limbs when compared to control and vehicle groups. Furthermore, fibroblast-delivered VEGF modRNA treatment increased the presence of Pax7
+ satellite cells, indicating a possible correlation between VEGF and satellite cell activity. Our study is the first to demonstrate that a cell-mediated modRNA therapy could be an alternative advanced strategy for cardiovascular diseases., (Copyright © 2019. Published by Elsevier B.V.)- Published
- 2019
- Full Text
- View/download PDF
17. Population and Single-Cell Analysis of Human Cardiogenesis Reveals Unique LGR5 Ventricular Progenitors in Embryonic Outflow Tract.
- Author
-
Sahara M, Santoro F, Sohlmér J, Zhou C, Witman N, Leung CY, Mononen M, Bylund K, Gruber P, and Chien KR
- Subjects
- Animals, Cell Differentiation genetics, Cell Line, Cells, Cultured, Embryonic Stem Cells metabolism, Endothelial Cells metabolism, Heart Ventricles metabolism, Human Embryonic Stem Cells metabolism, Humans, LIM-Homeodomain Proteins genetics, Mice, Inbred C57BL, Multipotent Stem Cells, Myocardium metabolism, Organogenesis, Cell Differentiation physiology, Myocytes, Cardiac metabolism, Receptors, G-Protein-Coupled metabolism, Single-Cell Analysis methods
- Abstract
The morphogenetic process of mammalian cardiac development is complex and highly regulated spatiotemporally by multipotent cardiac stem/progenitor cells (CPCs). Mouse studies have been informative for understanding mammalian cardiogenesis; however, similar insights have been poorly established in humans. Here, we report comprehensive gene expression profiles of human cardiac derivatives from multipotent CPCs to intermediates and mature cardiac cells by population and single-cell RNA-seq using human embryonic stem cell-derived and embryonic/fetal heart-derived cardiac cells micro-dissected from specific heart compartments. Importantly, we discover a uniquely human subset of cono-ventricular region-specific CPCs, marked by LGR5. At 4 to 5 weeks of fetal age, the LGR5
+ population appears to emerge specifically in the proximal outflow tract of human embryonic hearts and thereafter promotes cardiac development and alignment through expansion of the ISL1+ TNNT2+ intermediates. The current study contributes to a deeper understanding of human cardiogenesis, which may uncover the putative origins of certain human congenital cardiac malformations., (Copyright © 2019 Elsevier Inc. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
18. Lnc'ed in to Cardiogenesis.
- Author
-
Sahara M, Eroglu E, and Chien KR
- Subjects
- Animals, Mesoderm, Mice, T-Box Domain Proteins, Heart, RNA, Long Noncoding
- Abstract
Despite the continuous discovery of long noncoding RNAs (lncRNAs) with critical developmental roles, our knowledge of lncRNAs that control cardiac lineage commitment is still limited. In this issue, Guo et al. (2018) report a novel lncRNA-mediated multiprotein complex assembly that directly regulates the key transcriptional programs of murine cardiogenesis., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
19. Cardiac Progenitor Cells in Basic Biology and Regenerative Medicine.
- Author
-
Witman N and Sahara M
- Abstract
Major cardiovascular events including myocardial infarction (MI) continue to dominate morbidity rates in the developed world. Although multiple device therapies and various pharmacological agents have been shown to improve patient care and reduce mortality rates, clinicians and researchers alike still lack a true panacea to regenerate damaged cardiac tissue. Over the previous two to three decades, cardiovascular stem cell therapies have held great promise. Several stem cell-based approaches have now been shown to improve ventricular function and are documented in preclinical animal models as well as phase I and phase II clinical trials. More recently, the cardiac progenitor cell has begun to gain momentum as an ideal candidate for stem cell therapy in heart disease. Here, we will highlight the most recent advances in cardiac stem/progenitor cell biology in regard to both the basics and applied settings.
- Published
- 2018
- Full Text
- View/download PDF
20. Response to "Comment to the article 'Diverse contribution of bone marrow-derived late-outgrowth endothelial progenitor cells to vascular repair under pulmonary arterial hypertension and arterial neointimal formation'".
- Author
-
Ikutomi M, Minami Y, and Sahara M
- Subjects
- Arteries, Bone Marrow Cells, Humans, Hypertension, Pulmonary, Neointima, Bone Marrow, Endothelial Progenitor Cells
- Published
- 2017
- Full Text
- View/download PDF
21. Expansion of cardiac progenitors from reprogrammed fibroblasts as potential novel cardiovascular therapy.
- Author
-
Witman N and Sahara M
- Published
- 2016
- Full Text
- View/download PDF
22. Response to the letter by Guo et al., "Endothelial progenitor cells therapy: From bench to bedside".
- Author
-
Minami Y, Ikutomi M, and Sahara M
- Subjects
- Animals, Humans, Emergencies, Endothelial Progenitor Cells metabolism, Ischemia metabolism, Neovascularization, Physiologic physiology
- Published
- 2016
- Full Text
- View/download PDF
23. A specified therapeutic window for neuregulin-1 to regenerate neonatal heart muscle.
- Author
-
Santoro F and Sahara M
- Published
- 2015
- Full Text
- View/download PDF
24. Diverse contribution of bone marrow-derived late-outgrowth endothelial progenitor cells to vascular repair under pulmonary arterial hypertension and arterial neointimal formation.
- Author
-
Ikutomi M, Sahara M, Nakajima T, Minami Y, Morita T, Hirata Y, Komuro I, Nakamura F, and Sata M
- Subjects
- Animals, Arterioles growth & development, Arterioles transplantation, Bone Marrow Cells pathology, Bone Marrow Transplantation, Cell Differentiation genetics, Cell Proliferation, Endothelial Progenitor Cells drug effects, Endothelial Progenitor Cells metabolism, Endothelium, Vascular pathology, Femoral Artery drug effects, Femoral Artery injuries, Femoral Artery pathology, Humans, Hypertension, Pulmonary therapy, Monocrotaline administration & dosage, Neointima therapy, Rats, Vascular Diseases therapy, Endothelial Progenitor Cells transplantation, Endothelium, Vascular growth & development, Hypertension, Pulmonary pathology, Neointima pathology, Vascular Diseases pathology
- Abstract
Aims: It is still controversial whether bone marrow (BM)-derived endothelial progenitor cells (EPCs) can contribute to vascular repair and prevent the progression of vascular diseases. We aimed to characterize BM-derived EPC subpopulations and to evaluate their therapeutic efficacies to repair injured vascular endothelium of systemic and pulmonary arteries., Methods and Results: BM mononuclear cells of Fisher-344 rats were cultured under endothelial cell-conditions. Early EPCs appeared on days 3-6. Late-outgrowth and very late-outgrowth EPCs (LOCs and VLOCs) were defined as cells forming cobblestone colonies on days 9-14 and 17-21, respectively. Among EPC subpopulations, LOCs showed the highest angiogenic capability with enhanced proliferation potential and secretion of proangiogenic proteins. To investigate the therapeutic effects of these EPCs, Fisher-344 rats underwent wire-mediated endovascular injury in femoral artery (FA) and were concurrently injected intraperitoneally with 60mg/kg monocrotaline (MCT). Injured rats were then treated with six injections of one of three EPCs (1×10(6) per time). After 4weeks, transplanted LOCs, but not early EPCs or VLOCs, significantly attenuated neointimal lesion formation in injured FAs. Some of CD31(+) LOCs directly replaced the injured FA endothelium (replacement ratio: 11.7±7.0%). In contrast, any EPC treatment could neither replace MCT-injured endothelium of pulmonary arterioles nor prevent the progression of pulmonary arterial hypertension (PAH). LOCs modified protectively the expression profile of angiogenic and inflammatory genes in injured FAs, but not in MCT-injured lungs., Conclusion: BM-derived LOCs can contribute to vascular repair of injured systemic artery; however, even they cannot rescue injured pulmonary vasculature under MCT-induced PAH., (Copyright © 2015. Published by Elsevier Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
25. Programming and reprogramming a human heart cell.
- Author
-
Sahara M, Santoro F, and Chien KR
- Subjects
- Animals, Cell Proliferation physiology, Humans, Regenerative Medicine trends, Signal Transduction physiology, Species Specificity, Cell Lineage physiology, Cellular Reprogramming physiology, Heart embryology, Myocytes, Cardiac physiology, Regeneration physiology, Regenerative Medicine methods, Stem Cells physiology
- Abstract
The latest discoveries and advanced knowledge in the fields of stem cell biology and developmental cardiology hold great promise for cardiac regenerative medicine, enabling researchers to design novel therapeutic tools and approaches to regenerate cardiac muscle for diseased hearts. However, progress in this arena has been hampered by a lack of reproducible and convincing evidence, which at best has yielded modest outcomes and is still far from clinical practice. To address current controversies and move cardiac regenerative therapeutics forward, it is crucial to gain a deeper understanding of the key cellular and molecular programs involved in human cardiogenesis and cardiac regeneration. In this review, we consider the fundamental principles that govern the "programming" and "reprogramming" of a human heart cell and discuss updated therapeutic strategies to regenerate a damaged heart., (© 2015 The Authors.)
- Published
- 2015
- Full Text
- View/download PDF
26. Angiogenic potential of early and late outgrowth endothelial progenitor cells is dependent on the time of emergence.
- Author
-
Minami Y, Nakajima T, Ikutomi M, Morita T, Komuro I, Sata M, and Sahara M
- Subjects
- Animals, Cell Differentiation, Cell Proliferation, Cells, Cultured, Disease Models, Animal, Endothelial Progenitor Cells cytology, Flow Cytometry, Humans, Ischemia pathology, Mice, Mice, Inbred NOD, Mice, SCID, Emergencies, Endothelial Progenitor Cells metabolism, Ischemia metabolism, Neovascularization, Physiologic physiology
- Abstract
Background: Recent studies have suggested that late-outgrowth endothelial progenitor cells (EPCs) derived from human peripheral blood mononuclear cells (hPBMNCs) might have higher angiogenic potential than classically-defined early-outgrowth EPCs (EOCs). However, it still remains unclear which of "so-called" EPC subpopulations defined in a variety of ways has the highest angiogenic potential., Methods and Results: We classified hPBMNC-derived EPC subpopulations by the time of their emergence in culture. EOCs were defined as attached cells on culture days 3-7. Late-outgrowth EPCs, defined as the cell forming colonies with cobblestone appearance since day 10, were further classified as follows: "moderate"-outgrowth EPCs (MOCs) emerging on days 10-16, "late"-outgrowth EPCs (LOCs) on days 17-23, and "very late"-outgrowth EPCs (VOCs) on days 24-30. Flow cytometry analyses showed the clear differences of hematopoietic/endothelial markers between EOC (CD31(+)VE-cadherin(-)CD34(-)CD14(+)CD45(+)) and LOC (CD31(+)VE-cadherin(+)CD34(+)CD14(-)CD45(-)). We found that LOCs had the highest proliferation and tube formation capabilities in vitro along with the highest expression of angiogenic genes including KDR and eNOS. To investigate the in vivo therapeutic efficacies, each EPC subpopulation was intravenously transplanted into immunocompromised mice (total 4 × 10(5) cells) after unilateral hindlimb ischemia surgery. The LOC-treated mice exhibited significantly-enhanced blood flow recovery (flow ratios of ischemic/non-ischemic leg: 0.99±0.02 [LOC group] versus 0.67 ± 0.07 to 0.78 ± 0.09 [other groups]; P < 0.05) and augmented capillary collateral formation in ischemic leg, which were attributable to their direct engraftment into host angiogenic vessels (approximately 10%) and paracrine effects., Conclusion: hPBMNC-derived late-outgrowth EPCs emerging on culture days 17-23 are superior to other EPC subpopulations with regard to therapeutic angiogenic potential., (Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
27. Manipulation of a VEGF-Notch signaling circuit drives formation of functional vascular endothelial progenitors from human pluripotent stem cells.
- Author
-
Sahara M, Hansson EM, Wernet O, Lui KO, Später D, and Chien KR
- Published
- 2015
- Full Text
- View/download PDF
28. Manipulation of a VEGF-Notch signaling circuit drives formation of functional vascular endothelial progenitors from human pluripotent stem cells.
- Author
-
Sahara M, Hansson EM, Wernet O, Lui KO, Später D, and Chien KR
- Subjects
- Animals, Antigens, CD, Bone Morphogenetic Protein 4 pharmacology, Cadherins, Cell Differentiation drug effects, Cell Line, Endothelial Cells metabolism, Glycogen Synthase Kinase 3 antagonists & inhibitors, Glycogen Synthase Kinase 3 beta, Humans, Mice, Signal Transduction physiology, Vascular Endothelial Growth Factor Receptor-2 physiology, Embryonic Stem Cells cytology, Endothelium, Vascular metabolism, Pluripotent Stem Cells metabolism, Receptors, Notch physiology, Vascular Endothelial Growth Factor A physiology
- Abstract
Human pluripotent stem cell (hPSC)-derived endothelial lineage cells constitutes a promising source for therapeutic revascularization, but progress in this arena has been hampered by a lack of clinically-scalable differentiation protocols and inefficient formation of a functional vessel network integrating with the host circulation upon transplantation. Using a human embryonic stem cell reporter cell line, where green fluorescent protein expression is driven by an endothelial cell-specific VE-cadherin (VEC) promoter, we screened for > 60 bioactive small molecules that would promote endothelial differentiation, and found that administration of BMP4 and a GSK-3β inhibitor in an early phase and treatment with VEGF-A and inhibition of the Notch signaling pathway in a later phase led to efficient differentiation of hPSCs to the endothelial lineage within six days. This sequential approach generated > 50% conversion of hPSCs to endothelial cells (ECs), specifically VEC(+)CD31(+)CD34(+)CD14(-)KDR(high) endothelial progenitors (EPs) that exhibited higher angiogenic and clonogenic proliferation potential among endothelial lineage cells. Pharmaceutical inhibition or genetical knockdown of Notch signaling, in combination with VEGF-A treatment, resulted in efficient formation of EPs via KDR(+) mesodermal precursors and blockade of the conversion of EPs to mature ECs. The generated EPs successfully formed functional capillary vessels in vivo with anastomosis to the host vessels when transplanted into immunocompromised mice. Manipulation of this VEGF-A-Notch signaling circuit in our protocol leads to rapid large-scale production of the hPSC-derived EPs by 12- to 20-fold vs current methods, which may serve as an attractive cell population for regenerative vascularization with superior vessel forming capability compared to mature ECs.
- Published
- 2014
- Full Text
- View/download PDF
29. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
- Author
-
Sahara M, Ikutomi M, Morita T, Minami Y, Nakajima T, Hirata Y, Nagai R, and Sata M
- Subjects
- Angiotensin II metabolism, Angiotensin-Converting Enzyme 2, Animals, Aorta pathology, Aortic Diseases genetics, Aortic Diseases pathology, Apolipoproteins E deficiency, Apolipoproteins E genetics, Atherosclerosis genetics, Atherosclerosis pathology, Cell Proliferation, Cells, Cultured, Disease Models, Animal, Femoral Artery injuries, Femoral Artery pathology, Genetic Predisposition to Disease, Inflammation Mediators metabolism, JNK Mitogen-Activated Protein Kinases antagonists & inhibitors, JNK Mitogen-Activated Protein Kinases metabolism, Macrophages enzymology, Mice, Mice, Inbred C57BL, Mice, Knockout, Muscle, Smooth, Vascular enzymology, Muscle, Smooth, Vascular pathology, Myocytes, Smooth Muscle enzymology, Myocytes, Smooth Muscle pathology, Peptidyl-Dipeptidase A genetics, Phenotype, Protein Kinase Inhibitors pharmacology, RNA Interference, Signal Transduction, Transfection, Vascular System Injuries genetics, Vascular System Injuries pathology, Aorta enzymology, Aortic Diseases enzymology, Atherosclerosis enzymology, Femoral Artery enzymology, Gene Deletion, Neointima, Peptidyl-Dipeptidase A deficiency, Plaque, Atherosclerotic, Vascular System Injuries enzymology
- Abstract
Aims: Angiotensin-converting enzyme 2 (ACE2) is known as a negative regulator of the renin-angiotensin system. We aimed to determine the roles of ACE2 on the development of vascular diseases., Methods and Results: Using two diversely different models of vascular diseases, hyperlipidaemia-induced atherosclerosis in apolipoprotein E knockout (KO) mice and mechanical injury-induced arterial neointimal hyperplasia in C57Bl6 mice, we examined whether ACE2 deficiency could affect formation of the vascular lesions. ACE2 deficiency resulted in significantly larger vascular lesions in both aortic atherosclerotic plaques and arterial neointima formation, compared with ACE2(+) control. These ACE2-deficient vascular lesions exhibited enhanced accumulation of macrophages into the lesions and proliferation of vascular smooth muscle cells (VSMCs), accompanied with increased angiotensin-II (Ang-II) levels and enhanced expression of vascular inflammation-related genes, including vascular cell adhesion molecule (VCAM)-1, monocyte chemoattractant protein (MCP)-1, and matrix metalloproteinase (MMP)9 in aorta/artery tissues. Primary bone marrow macrophages and aortic VSMCs isolated from ACE2 KO mice also displayed enhanced pro-inflammatory responsiveness such as up-regulated gene/protein expression of VCAM-1, MCP-1, and MMP9 to stimulation with tumour necrosis factor-α and Ang-II. The similar phenotype was shown in human macrophages and aortic VSMCs that were transfected with ACE2-specific siRNA. In ACE2-deficient VSMCs, inhibition of c-Jun N-terminal kinase (JNK) by pharmacological blockade with SP600125 or genetic knockdown with JNK-specific siRNA significantly attenuated their pro-inflammatory phenotype., Conclusion: ACE2 deficiency promotes the development of vascular diseases associated with Ang-II-mediated vascular inflammation and activation of the JNK signalling, leading to the notion that ACE2 potentially confers protection against vascular diseases.
- Published
- 2014
- Full Text
- View/download PDF
30. Driving vascular endothelial cell fate of human multipotent Isl1+ heart progenitors with VEGF modified mRNA.
- Author
-
Lui KO, Zangi L, Silva EA, Bu L, Sahara M, Li RA, Mooney DJ, and Chien KR
- Subjects
- Cell Differentiation, Cells, Cultured, Endothelial Cells metabolism, Gene Expression Regulation, Developmental, Humans, LIM-Homeodomain Proteins analysis, LIM-Homeodomain Proteins metabolism, RNA, Messenger genetics, RNA, Messenger metabolism, Stem Cells metabolism, Transcription Factors analysis, Transcription Factors metabolism, Up-Regulation, Vascular Endothelial Growth Factor A analysis, Vascular Endothelial Growth Factor A genetics, Endothelial Cells cytology, Heart embryology, LIM-Homeodomain Proteins genetics, Myocardium cytology, Stem Cells cytology, Transcription Factors genetics, Vascular Endothelial Growth Factor A metabolism
- Abstract
Distinct families of multipotent heart progenitors play a central role in the generation of diverse cardiac, smooth muscle and endothelial cell lineages during mammalian cardiogenesis. The identification of precise paracrine signals that drive the cell-fate decision of these multipotent progenitors, and the development of novel approaches to deliver these signals in vivo, are critical steps towards unlocking their regenerative therapeutic potential. Herein, we have identified a family of human cardiac endothelial intermediates located in outflow tract of the early human fetal hearts (OFT-ECs), characterized by coexpression of Isl1 and CD144/vWF. By comparing angiocrine factors expressed by the human OFT-ECs and non-cardiac ECs, vascular endothelial growth factor (VEGF)-A was identified as the most abundantly expressed factor, and clonal assays documented its ability to drive endothelial specification of human embryonic stem cell (ESC)-derived Isl1+ progenitors in a VEGF receptor-dependent manner. Human Isl1-ECs (endothelial cells differentiated from hESC-derived ISL1+ progenitors) resemble OFT-ECs in terms of expression of the cardiac endothelial progenitor- and endocardial cell-specific genes, confirming their organ specificity. To determine whether VEGF-A might serve as an in vivo cell-fate switch for human ESC-derived Isl1-ECs, we established a novel approach using chemically modified mRNA as a platform for transient, yet highly efficient expression of paracrine factors in cardiovascular progenitors. Overexpression of VEGF-A promotes not only the endothelial specification but also engraftment, proliferation and survival (reduced apoptosis) of the human Isl1+ progenitors in vivo. The large-scale derivation of cardiac-specific human Isl1-ECs from human pluripotent stem cells, coupled with the ability to drive endothelial specification, engraftment, and survival following transplantation, suggest a novel strategy for vascular regeneration in the heart.
- Published
- 2013
- Full Text
- View/download PDF
31. A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells.
- Author
-
Später D, Abramczuk MK, Buac K, Zangi L, Stachel MW, Clarke J, Sahara M, Ludwig A, and Chien KR
- Subjects
- Animals, Biomarkers metabolism, Cell Differentiation, Cell Lineage, Cyclic Nucleotide-Gated Cation Channels metabolism, Embryo, Mammalian, Embryonic Stem Cells metabolism, Gene Expression Regulation, Developmental, Heart Atria cytology, Heart Atria embryology, Heart Atria metabolism, Heart Ventricles cytology, Heart Ventricles embryology, Heart Ventricles metabolism, Humans, Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels, Mesoderm cytology, Mesoderm metabolism, Mice, Muscle Proteins metabolism, Myocardium metabolism, Myocytes, Cardiac metabolism, Pluripotent Stem Cells metabolism, Potassium Channels, Cyclic Nucleotide-Gated Cation Channels genetics, Embryonic Stem Cells cytology, Morphogenesis, Muscle Proteins genetics, Myocardium cytology, Myocytes, Cardiac cytology, Pluripotent Stem Cells cytology
- Abstract
Most of the mammalian heart is formed from mesodermal progenitors in the first and second heart fields (FHF and SHF), whereby the FHF gives rise to the left ventricle and parts of the atria and the SHF to the right ventricle, outflow tract and parts of the atria. Whereas SHF progenitors have been characterized in detail, using specific molecular markers, comprehensive studies on the FHF have been hampered by the lack of exclusive markers. Here, we present Hcn4 (hyperpolarization-activated cyclic nucleotide-gated channel 4) as an FHF marker. Lineage-traced Hcn4+/FHF cells delineate FHF-derived structures in the heart and primarily contribute to cardiomyogenic cell lineages, thereby identifying an early cardiomyogenic progenitor pool. As a surface marker, HCN4 also allowed the isolation of cardiomyogenic Hcn4+/FHF progenitors from human embryonic stem cells. We conclude that a primary purpose of the FHF is to generate cardiac muscle and support the contractile activity of the primitive heart tube, whereas SHF-derived progenitors contribute to heart cell lineage diversification.
- Published
- 2013
- Full Text
- View/download PDF
32. The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response.
- Author
-
Higashikuni Y, Sainz J, Nakamura K, Takaoka M, Enomoto S, Iwata H, Tanaka K, Sahara M, Hirata Y, Nagai R, and Sata M
- Subjects
- ATP Binding Cassette Transporter, Subfamily G, Member 2, ATP-Binding Cassette Transporters genetics, Animals, Animals, Newborn, Antioxidants pharmacology, Cells, Cultured, Disease Models, Animal, Endothelial Cells drug effects, Genotype, Glutathione blood, Heart Failure genetics, Heart Failure metabolism, Heart Failure physiopathology, Hindlimb, Humans, Hypertrophy, Left Ventricular genetics, Hypertrophy, Left Ventricular metabolism, Hypertrophy, Left Ventricular physiopathology, Ischemia genetics, Ischemia metabolism, Ischemia physiopathology, Male, Mice, Mice, Knockout, Muscle, Skeletal blood supply, Myocytes, Cardiac drug effects, Neoplasm Proteins genetics, Phenotype, RNA Interference, Rats, Rats, Wistar, Time Factors, Transfection, Ventricular Function, Ventricular Remodeling, ATP-Binding Cassette Transporters metabolism, Antioxidants metabolism, Endothelial Cells metabolism, Glutathione metabolism, Heart Failure prevention & control, Hypertrophy, Left Ventricular prevention & control, Myocytes, Cardiac metabolism, Neoplasm Proteins metabolism, Neovascularization, Physiologic, Oxidative Stress drug effects
- Abstract
Objective: ATP-binding cassette transporter subfamily G member 2 (ABCG2), expressed in microvascular endothelial cells in the heart, has been suggested to regulate several tissue defense mechanisms. This study was performed to elucidate its role in pressure overload-induced cardiac hypertrophy., Methods and Results: Pressure overload was induced in 8- to 12-week-old wild-type and Abcg2-/- mice by transverse aortic constriction (TAC). Abcg2-/- mice showed exaggerated cardiac hypertrophy and ventricular remodeling after TAC compared with wild-type mice. In the early phase after TAC, functional impairment in angiogenesis and antioxidant response in myocardium was found in Abcg2-/- mice. In vitro experiments demonstrated that ABCG2 regulates transport of glutathione, an important endogenous antioxidant, from microvascular endothelial cells. Besides, glutathione transported from microvascular endothelial cells in ABCG2-dependent manner ameliorated oxidative stress-induced cardiomyocyte hypertrophy. In vivo, glutathione levels in plasma and the heart were increased in wild-type mice but not in Abcg2-/- mice after TAC. Treatment with the superoxide dismutase mimetic ameliorated cardiac hypertrophy in Abcg2-/- mice after TAC to the same extent as that in wild-type mice, although cardiac dysfunction with impaired angiogenesis was observed in Abcg2-/- mice., Conclusion: ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response.
- Published
- 2012
- Full Text
- View/download PDF
33. Nicorandil attenuates monocrotaline-induced vascular endothelial damage and pulmonary arterial hypertension.
- Author
-
Sahara M, Sata M, Morita T, Hirata Y, and Nagai R
- Subjects
- Animals, Antihypertensive Agents administration & dosage, Antihypertensive Agents pharmacology, Apoptosis drug effects, Blotting, Western, Caspase 3 metabolism, Cells, Cultured, Drug Therapy, Combination, Endothelium, Vascular pathology, Enzyme Inhibitors administration & dosage, Enzyme Inhibitors pharmacology, Familial Primary Pulmonary Hypertension, Glyburide administration & dosage, Glyburide pharmacology, Human Umbilical Vein Endothelial Cells drug effects, Human Umbilical Vein Endothelial Cells metabolism, Humans, Hypertension, Pulmonary chemically induced, Hypertension, Pulmonary physiopathology, Injections, Intraperitoneal, MAP Kinase Signaling System drug effects, Male, NG-Nitroarginine Methyl Ester administration & dosage, NG-Nitroarginine Methyl Ester pharmacology, Nicorandil administration & dosage, Phosphatidylinositol 3-Kinases metabolism, Proto-Oncogene Proteins c-akt metabolism, Random Allocation, Rats, Rats, Sprague-Dawley, Signal Transduction drug effects, Ventricular Pressure drug effects, Endothelium, Vascular drug effects, Hypertension, Pulmonary prevention & control, Monocrotaline toxicity, Nicorandil pharmacology
- Abstract
Background: An antianginal K(ATP) channel opener nicorandil has various beneficial effects on cardiovascular systems; however, its effects on pulmonary vasculature under pulmonary arterial hypertension (PAH) have not yet been elucidated. Therefore, we attempted to determine whether nicorandil can attenuate monocrotaline (MCT)-induced PAH in rats., Materials and Methods: Sprague-Dawley rats injected intraperitoneally with 60 mg/kg MCT were randomized to receive either vehicle; nicorandil (5.0 mg·kg(-1)·day(-1)) alone; or nicorandil as well as either a K(ATP) channel blocker glibenclamide or a nitric oxide synthase (NOS) inhibitor N(ω)-nitro-L-arginine methyl ester (L-NAME), from immediately or 21 days after MCT injection. Four or five weeks later, right ventricular systolic pressure (RVSP) was measured, and lung tissue was harvested. Also, we evaluated the nicorandil-induced anti-apoptotic effects and activation status of several molecules in cell survival signaling pathway in vitro using human umbilical vein endothelial cells (HUVECs)., Results: Four weeks after MCT injection, RVSP was significantly increased in the vehicle-treated group (51.0±4.7 mm Hg), whereas it was attenuated by nicorandil treatment (33.2±3.9 mm Hg; P<0.01). Nicorandil protected pulmonary endothelium from the MCT-induced thromboemboli formation and induction of apoptosis, accompanied with both upregulation of endothelial NOS (eNOS) expression and downregulation of cleaved caspase-3 expression. Late treatment with nicorandil for the established PAH was also effective in suppressing the additional progression of PAH. These beneficial effects of nicorandil were blocked similarly by glibenclamide and l-NAME. Next, HUVECs were incubated in serum-free medium and then exhibited apoptotic morphology, while these changes were significantly attenuated by nicorandil administration. Nicorandil activated the phosphatidylinositol 3-kinase (PI3K)/Akt and extracellular signal-regulated kinase (ERK) pathways in HUVECs, accompanied with the upregulation of both eNOS and Bcl-2 expression., Conclusions: Nicorandil attenuated MCT-induced vascular endothelial damage and PAH through production of eNOS and anti-apoptotic factors, suggesting that nicorandil might have a promising therapeutic potential for PAH.
- Published
- 2012
- Full Text
- View/download PDF
34. The ATP-binding cassette transporter BCRP1/ABCG2 plays a pivotal role in cardiac repair after myocardial infarction via modulation of microvascular endothelial cell survival and function.
- Author
-
Higashikuni Y, Sainz J, Nakamura K, Takaoka M, Enomoto S, Iwata H, Sahara M, Tanaka K, Koibuchi N, Ito S, Kusuhara H, Sugiyama Y, Hirata Y, Nagai R, and Sata M
- Subjects
- ATP Binding Cassette Transporter, Subfamily G, Member 2, Animals, Cell Survival, Female, Mice, Mice, Knockout, Recovery of Function, Wound Healing, ATP-Binding Cassette Transporters physiology, Endothelial Cells physiology, Microvessels physiopathology, Myocardial Infarction physiopathology, Neoplasm Proteins physiology
- Abstract
Objective: To clarify the impact of breast cancer resistance protein 1 (BCRP1)/ATP-binding cassette transporter subfamily G member 2 (ABCG2) expression on cardiac repair after myocardial infarction (MI)., Methods and Results: The ATP-binding cassette transporter BCRP1/ABCG2 is expressed in various organs, including the heart, and may regulate several tissue defense mechanisms. BCRP1/ABCG2 was mainly expressed in endothelial cells of microvessels in the heart. MI was induced in 8- to 12-week-old wild-type (WT) and Bcrp1/Abcg2 knockout (KO) mice by ligating the left anterior descending artery. At 28 days after MI, the survival rate was significantly lower in KO mice than in WT mice because of cardiac rupture. Echocardiographic, hemodynamic, and histological assessments showed that ventricular remodeling was more deteriorated in KO than in WT mice. Capillary, myofibroblast, and macrophage densities in the peri-infarction area at 5 days after MI were significantly reduced in KO compared with WT mice. In vitro experiments demonstrated that inhibition of BCRP1/ABCG2 resulted in accumulation of intracellular protoporphyrin IX and impaired survival of microvascular endothelial cells under oxidative stress. Moreover, BCRP1/ABCG2 inhibition impaired migration and tube formation of endothelial cells., Conclusions: BCRP1/ABCG2 plays a pivotal role in cardiac repair after MI via modulation of microvascular endothelial cell survival and function.
- Published
- 2010
- Full Text
- View/download PDF
35. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
- Author
-
Sahara M, Sata M, Morita T, Nakajima T, Hirata Y, and Nagai R
- Subjects
- Animals, Capillaries drug effects, Capillaries enzymology, Capillaries physiopathology, Cell Hypoxia, Cell Movement drug effects, Cells, Cultured, Collateral Circulation drug effects, Cyclic GMP metabolism, Cyclic Nucleotide Phosphodiesterases, Type 5 metabolism, Disease Models, Animal, Endothelial Cells drug effects, Endothelial Cells metabolism, Green Fluorescent Proteins biosynthesis, Green Fluorescent Proteins genetics, Hindlimb, Humans, Hypoxia-Inducible Factor 1, alpha Subunit genetics, Ischemia enzymology, Ischemia physiopathology, Male, Mice, Mice, Inbred C3H, Mice, Inbred C57BL, Mice, Knockout, Mice, Transgenic, Nitric Oxide Synthase Type III deficiency, Nitric Oxide Synthase Type III genetics, RNA Interference, Recovery of Function, Regional Blood Flow drug effects, Signal Transduction, Stem Cells drug effects, Stem Cells metabolism, Sulfones pharmacology, Time Factors, Transfection, Triazines pharmacology, Vardenafil Dihydrochloride, Vascular Endothelial Growth Factor A genetics, Angiogenesis Inducing Agents pharmacology, Cyclic GMP-Dependent Protein Kinases metabolism, Hypoxia-Inducible Factor 1, alpha Subunit metabolism, Imidazoles pharmacology, Ischemia drug therapy, Muscle, Skeletal blood supply, Neovascularization, Physiologic drug effects, Phosphodiesterase 5 Inhibitors, Phosphodiesterase Inhibitors pharmacology, Piperazines pharmacology, Vascular Endothelial Growth Factor A metabolism
- Abstract
Objective: We examined whether phosphodiesterase-5 (PDE5) inhibition can promote ischemia-induced angiogenesis., Methods and Results: Unilateral hindlimb ischemia was generated by resecting right femoral artery in wild-type C3H/He mice, treated with either vehicle or a PDE5 inhibitor vardenafil (10 mg/kg per day). Four weeks after surgery, vardenafil significantly enhanced blood flow recovery and augmented capillary collateral formation in ischemic muscle (blood flow ratios of ischemic/nonischemic leg: 0.52+/-0.17 [vehicle] versus 0.92+/-0.09 [vardenafil], P<0.01). Vardenafil upregulated protein expression of vascular endothelial growth factor and hypoxia-inducible factor (HIF)-1 alpha in ischemic muscle and enhanced mobilization of Sca-1/Flk-1-positive endothelial progenitor cells (EPCs) in peripheral blood and bone marrow, contributing to neovascularization. Vardenafil also promoted capillary-like tube formation of human umbilical vein endothelial cells and increased the number of human blood mononuclear cell-derived EPCs in vitro. Furthermore, reporter assays showed that vardenafil and cGMP activated the transactivation activity of HIF-1 under hypoxia. These effects of vardenafil were markedly inhibited by genetic ablation of endothelial nitric oxide synthase, a soluble guanylate cyclase inhibitor, and a protein kinase G inhibitor, respectively., Conclusions: Our results suggest that PDE5 inhibition enhances ischemia-induced angiogenesis with mobilization of EPCs through a protein kinase G-dependent HIF-1/vascular endothelial growth factor pathway. PDE5 inhibition may have a therapeutic potential to treat ischemic cardiovascular diseases.
- Published
- 2010
- Full Text
- View/download PDF
36. Infective endocarditis by Bartonella quintana masquerading as antineutrophil cytoplasmic antibody-associated small vessel vasculitis.
- Author
-
Sugiyama H, Sahara M, Imai Y, Ono M, Okamoto K, Kikuchi K, and Nagai R
- Subjects
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis diagnosis, Bartonella Infections blood, Diagnosis, Differential, Endocarditis blood, Endocarditis diagnosis, Humans, Male, Middle Aged, Antibodies, Antineutrophil Cytoplasmic blood, Bartonella Infections diagnosis, Bartonella quintana isolation & purification, Endocarditis microbiology
- Abstract
The Bartonella species have been recently recognized as important causative agents of culture-negative bacterial endocarditis. Antineutrophil cytoplasmic antibodies (ANCAs) have been associated with the spectrum of idiopathic small vessel vasculitis. However, a variety of infections can result in a false-positive ANCA test, and especially subacute bacterial endocarditis (SBE) with the presence of ANCAs occasionally mimics the clinical manifestations of an ANCA-associated vasculitis such as skin purpura and glomerulonephritis. In contrast, noninfectious endocardial involvement is known to be part of the spectrum of the manifestations of the ANCA-associated vasculitis. Therefore, it is crucial to distinguish an ANCA-positive SBE from an ANCA-associated vasculitis with endocardial compromise, because the misdiagnosis of an SBE as an ANCA-associated vasculitis can lead to an inappropriate immunosuppressive therapy with catastrophic consequences. The differential diagnosis is sometimes difficult, especially in the case of culture-negative infective endocarditis with a positive ANCA test. We describe here a case of a culture-negative SBE caused by Bartonellaquintana, accompanied with a positive cytoplasmic ANCA test and clinical findings masquerading as ANCA-associated vasculitis. Both a serological test for Bartonella and polymerase chain reaction restriction fragment length polymorphism analysis were helpful for a correct diagnosis and appropriate treatment., (Copyright 2009 S. Karger AG, Basel.)
- Published
- 2009
- Full Text
- View/download PDF
37. Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation.
- Author
-
Sahara M, Sata M, Morita T, Nakamura K, Hirata Y, and Nagai R
- Subjects
- Animals, Animals, Genetically Modified, Arterioles pathology, Bone Marrow Transplantation, Capillaries pathology, Cell Differentiation, Disease Models, Animal, Femoral Artery injuries, Femoral Artery pathology, Green Fluorescent Proteins genetics, Hypertension, Pulmonary therapy, Male, Monocrotaline pharmacology, Pneumonectomy, Pulmonary Embolism pathology, Rats, Rats, Sprague-Dawley, Thrombosis pathology, Tunica Intima pathology, Ventricular Dysfunction, Right pathology, Bone Marrow Cells pathology, Bone Marrow Cells physiology, Hypertension, Pulmonary pathology, Pulmonary Artery pathology
- Abstract
Background: Recent evidence suggests that bone marrow (BM)-derived cells may differentiate into vascular cells that participate in arterial repair and/or lesion formation. However, it remains uncertain whether BM-derived cells also can participate in vascular remodeling associated with pulmonary arterial hypertension., Methods and Results: The BM of Sprague-Dawley rats was reconstituted with that of green fluorescent protein-transgenic rats. The BM-chimeric rats were injected intraperitoneally with 60 mg/kg monocrotaline after unilateral subpneumonectomy, and they concurrently underwent wire-mediated endovascular injury in femoral artery. After 28 days, they had elevated right ventricular systolic pressure (58.8+/-5.4 versus 20.4+/-2.4 mm Hg in sham-control; P<0.01). The pulmonary arterioles were markedly thickened, with an infiltration of green fluorescent protein-positive macrophages into the perivascular areas. The endothelium of pulmonary arterioles contained only a few green fluorescent protein-positive cells, and green fluorescent protein-positive cells were seldom detected as smooth muscle cells in the lesions of thickened pulmonary arterioles. In contrast, BM-derived smooth muscle-like cells could be readily detected in the thickened neointima and media of the wire-injured femoral artery. Moreover, intravenous injection of 1x10(8) BM cells from young rats had no beneficial effects on pulmonary hypertension, pulmonary arterial remodeling, or survival in the aged rats treated with monocrotaline plus unilateral subpneumonectomy. No injected BM cell was identified as an endothelial cell or a smooth muscle cell., Conclusions: These results suggest that BM-derived cells can participate in arterial neointimal formation after mechanical injury, whereas they do not contribute substantially to pulmonary arterial remodeling associated with monocrotaline-induced pulmonary arterial hypertension in the pneumonectomized rats.
- Published
- 2007
- Full Text
- View/download PDF
38. New insights in the treatment strategy for pulmonary arterial hypertension.
- Author
-
Sahara M, Takahashi T, Imai Y, Nakajima T, Yao A, Morita T, Hirata Y, and Nagai R
- Subjects
- Anticoagulants therapeutic use, Calcium Channel Blockers therapeutic use, Diuretics therapeutic use, Drug Therapy, Combination, Humans, Male, Middle Aged, Nicorandil therapeutic use, Nitric Oxide Donors therapeutic use, Oxygen Inhalation Therapy, Phosphodiesterase Inhibitors therapeutic use, Piperazines therapeutic use, Purines therapeutic use, Pyridazines therapeutic use, Sildenafil Citrate, Sulfones therapeutic use, Vasodilator Agents therapeutic use, Antihypertensive Agents therapeutic use, Hypertension, Pulmonary therapy
- Abstract
Introduction: Recent advances in our understanding of the pathophysiological and molecular mechanisms involved in pulmonary arterial hypertension have led to the development of novel and rational pharmacological therapies. In addition to conventional therapy (i.e., supplemental oxygen and calcium channel blockers), prostacyclin or endothelin receptor antagonists have been recommended as a first-line therapy for pulmonary arterial hypertension. However, these treatments have potential limitations with regard to their long-term efficacy and improvement in survival. Furthermore, intravenous prostacyclin (epoprostenol) therapy, which is recommended by most experts for patients with New York Heart Association (NYHA) functional class IV, is complicated, uncomfortable for patients, and expensive because of the cumbersome administration system. Considering these circumstances, it is necessary to develop additional novel therapeutic approaches that target the various components of this multifactorial disease., Case Report: In this short review, we present an overview of the current treatment options for pulmonary arterial hypertension and describe a case report with primary pulmonary hypertension. A male patient with NYHA functional class IV and showing no response to calcium channel blockers and prostacyclin exhibited significantly improved exercise tolerance and hemodynamics and long-term survival for more than 2.5 years after receiving an oral combination therapy of a phosphodiesterase type 5 inhibitor (sildenafil), phosphodiesterase type 3 inhibitor (pimobendan), and nicorandil., Future Perspective: We also discuss the background and plausible potential mechanisms involved in this case, as well as future perspectives in the treatment of pulmonary arterial hypertension.
- Published
- 2006
- Full Text
- View/download PDF
39. Three-vessel coronary artery disease complicated with congestive heart failure in a highly aged patient with tetralogy of Fallot having undergone palliative surgeries.
- Author
-
Sahara M, Takahashi T, Morita T, Yao A, Nagashima Y, Hirata Y, and Nagai R
- Subjects
- Aged, Angioplasty, Balloon, Coronary, Atherectomy, Atherectomy, Coronary, Coronary Disease therapy, Female, Humans, Hypercholesterolemia complications, Hypoxia etiology, Imaging, Three-Dimensional, Palliative Care, Pulmonary Edema etiology, Pulmonary Subvalvular Stenosis etiology, Stents, Tetralogy of Fallot diagnostic imaging, Tetralogy of Fallot surgery, Tomography, X-Ray Computed, Coronary Disease complications, Heart Failure complications, Tetralogy of Fallot complications
- Abstract
An increasing number of patients with tetralogy of Fallot (TOF) are reaching older age. We encountered a 75-year-old woman with uncorrected TOF and concomitant severe coronary artery disease (CAD) with congestive heart failure. Her CAD risk factor was hyperlipidemia, which had been untreated. Successful percutaneous coronary interventions have improved her clinical condition and provided long-term survival. Although CAD is considered to be a rare complication in adults with TOF, both strict modification of CAD risk factors and early detection of CAD would be also required in this population, given the residual TOF lesions relating to acute exacerbation of clinical presentation.
- Published
- 2006
- Full Text
- View/download PDF
40. Comparison of various bone marrow fractions in the ability to participate in vascular remodeling after mechanical injury.
- Author
-
Sahara M, Sata M, Matsuzaki Y, Tanaka K, Morita T, Hirata Y, Okano H, and Nagai R
- Subjects
- Animals, Antigens, CD34 biosynthesis, Bone Marrow Cells metabolism, Cell Differentiation, Cell Transplantation, Green Fluorescent Proteins metabolism, Hematopoietic Stem Cell Transplantation, Mice, Mice, Inbred C57BL, Mice, Transgenic, Microscopy, Fluorescence, Stem Cell Transplantation, Time Factors, Blood Vessels cytology, Bone Marrow Cells cytology, Endothelium, Vascular cytology, Stem Cells cytology
- Abstract
In contrast to conventional assumption, recent reports propose the possibility that hematopoietic stem cells (HSCs) may have broader potential to differentiate into various cell types. Here, we tested the pluripotency of HSCs by comparing vascular lesions induced by mechanical injury after bone marrow reconstitution with total bone marrow (TBM) cells, c-Kit+ Sca-1+ Lin- (KSL) cells, or a single HSC cell (Tip-SP CD34-KSL cell, CD34- c-Kit+ Sca-1+ Lin- cell with the strongest dye-efflux activity) harboring green fluorescent protein (GFP). The lesions contained a significant number of GFP-positive cells in the TBM and KSL groups, whereas GFP-positive cells were rarely detected in the HSC group. These results suggest that transdifferentiation of a highly purified HSC seems to be a rare event, if it occurs at all, whereas bone marrow cells including the KSL fraction can give rise to vascular cells that substantially contribute to repair or lesion formation after mechanical injury.
- Published
- 2005
- Full Text
- View/download PDF
41. Soft plaque detected on intravascular ultrasound is the strongest predictor of in-stent restenosis: an intravascular ultrasound study.
- Author
-
Sahara M, Kirigaya H, Oikawa Y, Yajima J, Nagashima K, Hara H, Ogasawara K, and Aizawa T
- Subjects
- Aged, Coronary Restenosis pathology, Coronary Restenosis therapy, Female, Humans, Male, Multivariate Analysis, Prognosis, Retrospective Studies, Coronary Restenosis diagnostic imaging, Endosonography, Stents
- Abstract
Aims: Although various predictors of in-stent restenosis (ISR) have been reported, the subject of parameters relating to ISR on intravascular ultrasound (IVUS) still leaves room for discussion. The aim of this study was to clarify the strongest predictors of ISR using IVUS., Methods and Results: Ninety-two native coronary lesions undergoing single bare-metallic stent implantation were investigated retrospectively. We classified them into the ISR (n=46) and non-ISR (n=46) groups using quantitative coronary angiography. On serial IVUS studies, plaque morphology, and areas and volumes of each component in vessel were evaluated. Among all parameters, diabetes mellitus and soft plaque appearing hypoechoic on IVUS were associated with ISR. By multivariate analysis, soft plaque was the only independent predictor of ISR (p=0.0057). Compared with non-soft plaque, soft plaque had a larger plaque reduction rate (-7.1% vs. -1.6%, p=0.0613) and smaller percent plaque volume (53.0% vs. 55.5%, p=0.0273) after stenting. Conversely, soft plaque had a larger neointimal area (4.39 vs. 3.33 mm2, p=0.0437) and percent plaque area (80.5% vs. 75.1%, p=0.0503) at follow-up., Conclusion: Soft plaque detected on IVUS was the strongest predictor of ISR. Soft plaque was compressed more easily by stenting, however, causing more proliferation of neointima subsequently and resulted in a worse prognosis.
- Published
- 2004
- Full Text
- View/download PDF
42. A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease.
- Author
-
Ogasawara K, Mashiba S, Wada Y, Sahara M, Uchida K, Aizawa T, and Kodama T
- Subjects
- Aged, Biomarkers blood, Cohort Studies, Confidence Intervals, Coronary Angiography, Coronary Artery Disease diagnostic imaging, Female, Humans, Logistic Models, Male, Middle Aged, Odds Ratio, Probability, Prognosis, Prospective Studies, Risk Assessment, Severity of Illness Index, Coronary Artery Disease blood, Lipoproteins, LDL blood, Serum Amyloid A Protein analysis
- Abstract
Background: Although some reports have indicated that acute phase proteins such as C-reactive protein (CRP) and serum amyloid A (SAA) can predict the prognosis in patients with acute coronary syndrome, the value of these markers in patients with stable coronary artery disease (CAD) still remains obscure. Therefore, our aim was to determine the prognostic value of inflammatory markers in patients with stable coronary artery disease., Methods and Results: We conducted a prospective cohort study in 140 consecutive patients with stable coronary artery disease who had at least one coronary stenosis more than 50% in diameter seen on diagnostic coronary angiography (CAG). We determined serum levels of the SAA/LDL complex as a new marker in addition to CRP and SAA. Serum levels of the SAA/LDL complex were measured by a sandwich enzyme-linked immunosorbent assay (ELISA). End-points were defined as cardiac death, myocardial infarction, cerebral infarction, and coronary revascularization. End-point events occurred in 21 patients (2 death from myocardial infarction, 2 cerebral infarction, and 17 revascularization). Age (year) (OR = 1.14, CI: 1.05-1.25), diabetes mellitus (OR = 3.50, CI: 1.08-11.40), triglyceride (10mg/dl) (OR = 1.12, CI: 1.01-1.23) and SAA/LDL complex (10 microg/ml) (OR = 2.32, CI: 1.05-4.70) were independently related to the events. A reconstitution experiment suggested that the SAA/LDL complex is derived by oxidative interaction between SAA and lipoproteins., Conclusions: The SAA/LDL complex reflects intravascular inflammation directly and can be a new marker more sensitive than CRP or SAA for prediction of prognosis in patients with stable coronary artery disease.
- Published
- 2004
- Full Text
- View/download PDF
43. [Sex differences in coronary atherosclerosis: coronary angiography and intravascular ultrasonography].
- Author
-
Hara H, Yajima J, Kirigaya H, Nagashima K, Oikawa Y, Sahara M, Nakatsu Y, and Aizawa T
- Subjects
- Aged, Calcinosis diagnostic imaging, Coronary Artery Disease therapy, Coronary Vessels pathology, Female, Humans, Male, Middle Aged, Prognosis, Sex Factors, Angioplasty, Balloon, Coronary, Coronary Angiography, Coronary Artery Disease diagnostic imaging, Ultrasonography, Interventional
- Abstract
Objectives: Women have higher mortality and frequency of complications compared with men after coronary intervention. Possible differences in coronary atherosclerosis between men and women were investigated., Methods: The left anterior descending arteries of 214 patients (164 men, mean age 62.3 +/- 9.10 years; 50 women, mean age 67.8 +/- 7.76 years) were examined. Lesion length, reference diameter, percentage diameter stenosis and minimal lumen diameter were measured by quantitative coronary angiography. Vessel area, lumen area, percentage area stenosis, and remodeling index were measured by intravascular ultrasonography, and presence of calcification in the lesion was classified. These parameters were compared between men and women., Results: There were no significant differences in quantitative coronary angiography, but intravascular ultrasonography showed calcification was more severe in women, vessel area was significantly smaller in women (13.25 +/- 4.21 vs 15.91 +/- 4.35 mm2, p = 0.004), and remodeling index was significantly lower in women (0.95 +/- 0.13 vs 1.04 +/- 0.18, p = 0.015)., Conclusions: Vessel area measured by intravascular ultrasonography was significantly smaller in women, and calcification was more severe in women. Such factors may be involved in the higher mortality in women.
- Published
- 2004
44. [Development of blood examination method of serum amyloid A and LDL complex, and clinical application to prediction of cardiovascular event].
- Author
-
Mashiba S, Ogasawara K, Takeya M, Wada Y, Sahara M, Kojima S, Tabata K, Ueda M, Uchida K, Aizawa T, and Kodama T
- Subjects
- Acute-Phase Proteins analysis, Biomarkers blood, Enzyme-Linked Immunosorbent Assay, Humans, Prognosis, Sensitivity and Specificity, Coronary Disease diagnosis, Lipoproteins, LDL blood, Serum Amyloid A Protein analysis
- Abstract
In recent years, it has been reported that the acute-phase proteins C-reactive protein(CRP) and serum amyloid A(SAA), the sera levels of which are elevated in inflammation, are also elevated in coronary artery disease such as acute myocardial infarction. Also, high-sensitivity CRP assay is thought to be useful in predicting the prognosis of coronary heart disease. While investigating complexes of acute-phase proteins and low-density lipoprotein(LDL), we found a complex of LDL and SAA(SAA/LDL complex). The SAA/LDL complex in blood are formed from LDL and HDL by an oxidation reaction. Therefore, we developed an ELISA using anti-human SAA antibody and anti-human apoB, and determined a new method for measuring SAA/LDL complex in sera. We evaluated SAA/LDL complex as a new marker for prediction of prognosis in addition to the ordinary markers in consecutive 140 patients with stable coronary heart disease who had at least 1 coronary artery stenosis more than 50% in diameter at the diagnostic coronary angiography. Of these 140 patients, 2 developed fatal myocardial infarction, 2 cerebral infarction, and 17 angina pectoris requiring coronary revascularization therapy during 1 year and 6 months after blood examinations. The SAA/LDL complex value in this EVENT group of 21 patients was significantly higher than that in the control group of 119 individuals. High-sensitivity CRP (hs-CRP) assay and SAA measurement showed no significant difference between the 2 groups. The SAA/LDL complex reflects intravascular inflammation directly and can be a new marker more sensitive than hs-CRP or SAA for prediction of prognosis in patients with stable coronary artery disease.
- Published
- 2004
45. Arterial remodeling patterns before intervention predict diffuse in-stent restenosis: an intravascular ultrasound study.
- Author
-
Sahara M, Kirigaya H, Oikawa Y, Yajima J, Ogasawara K, Satoh H, Nagashima K, Hara H, Nakatsu Y, and Aizawa T
- Subjects
- Aged, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Retrospective Studies, Stents adverse effects, Angioplasty, Balloon, Coronary adverse effects, Arteries physiology, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease physiopathology, Coronary Restenosis diagnostic imaging, Coronary Restenosis physiopathology, Ultrasonography, Interventional methods
- Abstract
Objectives: The aim of this retrospective study was to determine the predictors of diffuse in-stent restenosis (ISR) among the lesions causing the first ISR by intravascular ultrasound (IVUS) studies., Background: Although some predictors of diffuse ISR have been reported, parameters on IVUS relating to diffuse ISR are not well characterized., Methods: We classified 52 ISR lesions that had undergone successful stent implantation and led to restenosis into two types--focal and diffuse ISR--using quantitative coronary angiography. Restenosis was defined as > or =50% diameter stenosis, and diffuse ISR as lesion length > or =10 mm at follow-up. The remodeling index (RI) was defined as the vessel area at the target lesion divided by that of averaged reference segments., Results: There were no significant differences in patient, angiographic, and procedural characteristics between the focal (n = 25) and diffuse (n = 27) ISR groups. Baseline RI was significantly greater in the diffuse ISR group (1.03 +/- 0.18 vs. 0.88 +/- 0.24, p = 0.0159). Negative remodeling, defined as RI <0.9, was detected in 60% of the focal ISR group and in only 26% of the diffuse ISR group. By logistic regression analysis, baseline RI was the only independent predictor of diffuse ISR (p = 0.0341). Moreover, volumetric analyses revealed that lesions developing into diffuse ISR had less capacity to compensate for further plaque growth., Conclusions: Among the first ISR lesions, baseline positive remodeling was the most powerful predictor of diffuse ISR. Measuring pre-interventional arterial remodeling patterns by IVUS may be helpful to stratify lesions at higher risk.
- Published
- 2003
- Full Text
- View/download PDF
46. Nifekalant hydrochloride, a novel class III antiarrhythmic agent, suppressed postoperative recurrent ventricular tachycardia in a patient undergoing coronary artery bypass grafting and the Dor approach.
- Author
-
Sahara M, Sagara K, Yamashita T, Iinuma H, Fu LT, and Watanabe H
- Subjects
- Aged, Anti-Arrhythmia Agents classification, Drug Resistance, Electric Countershock, Electrocardiography, Humans, Lidocaine therapeutic use, Male, Mexiletine therapeutic use, Tachycardia, Ventricular diagnosis, Tachycardia, Ventricular therapy, Anti-Arrhythmia Agents therapeutic use, Coronary Artery Bypass adverse effects, Potassium Channel Blockers therapeutic use, Pyrimidinones therapeutic use, Tachycardia, Ventricular drug therapy, Tachycardia, Ventricular etiology
- Abstract
A patient with 3-vessel coronary artery disease and left ventricular aneurysm underwent coronary artery bypass grafting combined with the Dor approach. Five days later, ventricular tachycardia following short-coupled ventricular premature contractions suddenly occurred and was not responsive to class IB drugs (lidocaine and mexiletine), requiring frequent electrical cardioversion. After the administration of a novel class III drug, nifekalant hydrochloride, this electrical storm of ventricular tachycardia was completely suppressed together with the disappearance of ventricular premature contractions. Nifekalant hydrochloride (MS-551), a pure K(+) channel blocker, might be effective for postoperative recurrent ventricular tachyarrhythmias that are refractory to other antiarrhythmic agents.
- Published
- 2003
- Full Text
- View/download PDF
47. [Prevention and treatment of the severe complications of myocardial infarction in chronic phase].
- Author
-
Sahara M, Sagara K, and Watanabe H
- Subjects
- Arrhythmias, Cardiac prevention & control, Chronic Disease, Heart Failure prevention & control, Humans, Myocardial Infarction therapy, Ventricular Remodeling physiology, Arrhythmias, Cardiac therapy, Heart Failure therapy, Myocardial Infarction complications
- Published
- 2003
48. Mechanisms of acute gain and late lumen loss after atherectomy in different preintervention arterial remodeling patterns.
- Author
-
Oikawa Y, Kirigaya H, Aizawa T, Nagashima K, Yajima J, Ishimura K, Hara H, Sahara M, Iinuma H, and Fu LT
- Subjects
- Adult, Aged, Aged, 80 and over, Coronary Angiography, Coronary Artery Disease diagnosis, Female, Follow-Up Studies, Humans, Male, Middle Aged, Ultrasonography, Interventional, Atherectomy, Coronary, Coronary Disease surgery, Coronary Restenosis diagnosis, Postoperative Complications diagnosis
- Abstract
The main mechanism of restenosis after directional coronary atherectomy (DCA) remains obscure. We investigated mechanisms of restenosis after DCA in different coronary artery remodeling patterns. DCA was performed in 51 de novo lesions. The lesions were evaluated by intravascular ultrasound (IVUS) before, immediately after, and 6 months after the procedure. According to the IVUS findings before DCA, we classified the lesions into the following 3 groups: (1) positive (n = 10), (2) intermediate (n = 25), and (3) negative (n = 16) remodeling. We measured lumen area, vessel area, and plaque area using IVUS before DCA, immediately after DCA, and at follow-up. Lumen area increase after DCA was mainly due to plaque area reduction in the positive and intermediate remodeling groups (90 plus minus 15% and 80 plus minus 25% increase in lumen area, respectively), whereas that in the negative remodeling group was due to both plaque area reduction (57 plus minus 22% increase in lumen area) and vessel area enlargement (43 plus minus 33% increase in lumen area). The plaque area increase correlated strongly with late lumen area loss in the positive and intermediate remodeling groups (r = 0.884, p <0.001; r = 0.626, p <0.001, respectively), but the decrease in vessel area was not correlated with lumen area loss. In contrast, both an increase in plaque area and a decrease in vessel area were correlated with late lumen area loss (r = 0.632, p = 0.009; r = 0.515, p = 0.041) in the negative remodeling group. Coronary artery restenosis after atherectomy was primarily due to an increase in plaque in the positive and/or intermediate remodeling groups. However, in the negative remodeling group, late lumen loss might have been caused by both an increase in plaque and vessel shrinkage.
- Published
- 2002
- Full Text
- View/download PDF
49. J wave and ST segment elevation in the inferior leads: a latent type of variant Brugada syndrome?
- Author
-
Sahara M, Sagara K, Yamashita T, Abe T, Kirigaya H, Nakada M, Iinuma H, Fu LT, and Watanabe H
- Subjects
- Adult, Diagnosis, Differential, Humans, Lidocaine analogs & derivatives, Lidocaine pharmacology, Male, Sodium Channel Blockers pharmacology, Syndrome, Ventricular Fibrillation diagnosis, Bundle-Branch Block diagnosis, Electrocardiography, Tachycardia, Ventricular diagnosis
- Abstract
In a patient referred for the evaluation of non-sustained monomorphic ventricular tachycardia on Holter recordings, ventricular fibrillation was electrically induced during electrophysiologic study. Despite the absence of structural heart diseases, his ECG revealed J wave and ST segment elevation in the inferior leads, which showed circadian variation and were augmented by the sodium channel blocker, pilsicainide. This case might lead us to notice a new concept, a 'latent' type of variant Brugada syndrome, and these ECG findings and changes might serve as its diagnostic sign.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.